LPL Financial LLC

Position in OCGN — Ocugen, Inc.

CIK 1403438 FORT MILL, SC

Position in OCGN

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$25,738

+$6,676 QoQ

Shares Held

14,220

+0.7% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

LPL Financial LLC holds $459,538,719 across 201 Biotechnology names. OCGN ranks #174 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	268,062	$119,700,405
2	REGN	Regeneron Pharmaceuticals, Inc.	63,987	$49,438,915
3	INSM	INSMED Inc	138,281	$22,611,709
4	ALNY	Alnylam Pharmaceuticals, Inc.	67,637	$22,379,054
5	EXEL	Exelixis, Inc.	399,612	$17,139,358
6	ARGX	Argenx SE	23,247	$16,976,121
7	HALO	Halozyme Therapeutics, Inc.	194,304	$12,557,867
8	ROIV	Roivant Sciences Ltd.	378,656	$10,488,771

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$25,738	14,220	+0.7%	Shares	Sole	2026-05-06
2025-12-31	$19,062	14,120	-73.8%	Shares	Sole	2026-02-11
2025-06-30	$52,370	53,990	+409.8%	Shares	Sole	2025-08-12
2022-12-31	$13,767	10,590	-2.8%	Shares	Sole	2023-02-07
2022-09-30	$19,384	10,890	-22.0%	Shares	Sole	2022-11-14
2022-06-30	$31,689	13,960	-1.8%	Shares	Sole	2022-08-12
2022-03-31	$46,893	14,210	-36.7%	Shares	Sole	2022-05-16
2021-12-31	$102,211	22,464	-58.4%	Shares	Sole	2022-02-14
2021-09-30	$387,791	54,010	+285.0%	Shares	Sole	2021-11-15
2021-06-30	$112,660	14,030	-65.5%	Shares	Sole	2021-08-13
2021-03-31	$276,217	40,680	+25.2%	Shares	Sole	2021-05-14
2020-12-31	$59,475	32,500	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.